Full Coverage

Cytopia Commences Second Phase II Study in Brain Cancer

                   
earthtimes.org
04-Sep-2008
        
Story Timeline:  91 days

MELBOURNE, Australia, Sept. 4 Cytopia-Cancer-Study MELBOURNE, Australia, Sept. 4 /PRNewswire/ -- Cytopia Limited (ASX: CYT) today announced that it is commencing enrolment for its Phase Ib/II study of CYT997, the company's novel vascular-disrupting anticancer agent, in patients with an aggressive form of brain cancer known as glioblastoma multiforme (GBM). The GBM clinical trial is the first Phase II efficacy... [read full story]                    

Add Comment
Latest article on this story:

Cytopia Initiates Enrollment for Second Phase II Brain Cancer Study

 redorbit.com 05-Sep-2008
First article on this story:

Cytopia Commences Second Phase II Study in Brain Cancer

 prnewswire.com 04-Sep-2008
Selected publications with coverage of this story:
redorbit.com prnewswire.com earthtimes.org
RELATED
No documents found.